nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—ABCB1—Desloratadine—allergic rhinitis	0.0214	0.156	CbGbCtD
Bosutinib—CYP3A4—Flunisolide—allergic rhinitis	0.0128	0.0934	CbGbCtD
Bosutinib—ABCB1—Loratadine—allergic rhinitis	0.0123	0.0895	CbGbCtD
Bosutinib—CYP3A4—Olopatadine—allergic rhinitis	0.012	0.0878	CbGbCtD
Bosutinib—ABCB1—Methylprednisolone—allergic rhinitis	0.0112	0.0819	CbGbCtD
Bosutinib—CYP3A4—Loratadine—allergic rhinitis	0.00735	0.0536	CbGbCtD
Bosutinib—CYP3A4—Montelukast—allergic rhinitis	0.00735	0.0536	CbGbCtD
Bosutinib—ABCB1—Betamethasone—allergic rhinitis	0.00729	0.0532	CbGbCtD
Bosutinib—ABCB1—Prednisolone—allergic rhinitis	0.0072	0.0525	CbGbCtD
Bosutinib—ABCB1—Hydrocortisone—allergic rhinitis	0.00682	0.0498	CbGbCtD
Bosutinib—CYP3A4—Methylprednisolone—allergic rhinitis	0.00672	0.049	CbGbCtD
Bosutinib—CYP3A4—Triamcinolone—allergic rhinitis	0.00509	0.0372	CbGbCtD
Bosutinib—CYP3A4—Betamethasone—allergic rhinitis	0.00437	0.0319	CbGbCtD
Bosutinib—CYP3A4—Prednisolone—allergic rhinitis	0.00431	0.0315	CbGbCtD
Bosutinib—ABCB1—Dexamethasone—allergic rhinitis	0.00424	0.031	CbGbCtD
Bosutinib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00409	0.0298	CbGbCtD
Bosutinib—CYP3A4—Dexamethasone—allergic rhinitis	0.00254	0.0186	CbGbCtD
Bosutinib—BMPR2—respiratory system—allergic rhinitis	0.0013	0.00465	CbGeAlD
Bosutinib—DMPK—trachea—allergic rhinitis	0.00128	0.00457	CbGeAlD
Bosutinib—WEE1—trachea—allergic rhinitis	0.00128	0.00457	CbGeAlD
Bosutinib—PLK2—skin of body—allergic rhinitis	0.00128	0.00456	CbGeAlD
Bosutinib—MAP4K4—respiratory system—allergic rhinitis	0.00125	0.00447	CbGeAlD
Bosutinib—CAMK1D—bronchus—allergic rhinitis	0.00125	0.00446	CbGeAlD
Bosutinib—BCR—respiratory system—allergic rhinitis	0.00124	0.00444	CbGeAlD
Bosutinib—STK3—eye—allergic rhinitis	0.00124	0.00443	CbGeAlD
Bosutinib—STK24—bronchus—allergic rhinitis	0.00123	0.00441	CbGeAlD
Bosutinib—ROCK1—eye—allergic rhinitis	0.00122	0.00437	CbGeAlD
Bosutinib—STK25—trachea—allergic rhinitis	0.00122	0.00436	CbGeAlD
Bosutinib—MAP2K1—respiratory system—allergic rhinitis	0.00121	0.00432	CbGeAlD
Bosutinib—CSK—respiratory system—allergic rhinitis	0.0012	0.00429	CbGeAlD
Bosutinib—FER—bronchus—allergic rhinitis	0.00119	0.00427	CbGeAlD
Bosutinib—CSNK1A1—respiratory system—allergic rhinitis	0.00119	0.00427	CbGeAlD
Bosutinib—STK24—skin of body—allergic rhinitis	0.00119	0.00426	CbGeAlD
Bosutinib—PLK2—trachea—allergic rhinitis	0.00119	0.00424	CbGeAlD
Bosutinib—CLK1—respiratory system—allergic rhinitis	0.00119	0.00424	CbGeAlD
Bosutinib—MAP4K1—bronchus—allergic rhinitis	0.00117	0.00418	CbGeAlD
Bosutinib—MERTK—eye—allergic rhinitis	0.00117	0.00416	CbGeAlD
Bosutinib—BTK—bronchus—allergic rhinitis	0.00116	0.00416	CbGeAlD
Bosutinib—CAMK2G—respiratory system—allergic rhinitis	0.00116	0.00416	CbGeAlD
Bosutinib—TYRO3—skin of body—allergic rhinitis	0.00115	0.00412	CbGeAlD
Bosutinib—LRRK2—respiratory system—allergic rhinitis	0.00115	0.00412	CbGeAlD
Bosutinib—TLK1—lung—allergic rhinitis	0.00115	0.00411	CbGeAlD
Bosutinib—BCR—eye—allergic rhinitis	0.00114	0.00406	CbGeAlD
Bosutinib—ERBB4—epithelium—allergic rhinitis	0.00113	0.00405	CbGeAlD
Bosutinib—PRKCQ—lung—allergic rhinitis	0.00113	0.00405	CbGeAlD
Bosutinib—MAP3K12—eye—allergic rhinitis	0.00113	0.00403	CbGeAlD
Bosutinib—PTK2B—respiratory system—allergic rhinitis	0.00112	0.00402	CbGeAlD
Bosutinib—CAMK1D—trachea—allergic rhinitis	0.00112	0.00401	CbGeAlD
Bosutinib—ROCK1—epithelium—allergic rhinitis	0.00112	0.004	CbGeAlD
Bosutinib—STK33—lung—allergic rhinitis	0.00112	0.004	CbGeAlD
Bosutinib—STK3—bronchus—allergic rhinitis	0.00112	0.00399	CbGeAlD
Bosutinib—STK24—trachea—allergic rhinitis	0.00111	0.00396	CbGeAlD
Bosutinib—CSNK1E—respiratory system—allergic rhinitis	0.00111	0.00395	CbGeAlD
Bosutinib—MAP2K1—eye—allergic rhinitis	0.0011	0.00395	CbGeAlD
Bosutinib—CSK—eye—allergic rhinitis	0.0011	0.00392	CbGeAlD
Bosutinib—CSNK1A1—eye—allergic rhinitis	0.00109	0.0039	CbGeAlD
Bosutinib—SIK1—respiratory system—allergic rhinitis	0.00109	0.00389	CbGeAlD
Bosutinib—CLK1—eye—allergic rhinitis	0.00108	0.00387	CbGeAlD
Bosutinib—FER—trachea—allergic rhinitis	0.00107	0.00383	CbGeAlD
Bosutinib—BMPR2—bronchus—allergic rhinitis	0.00107	0.00383	CbGeAlD
Bosutinib—ERBB3—respiratory system—allergic rhinitis	0.00107	0.00381	CbGeAlD
Bosutinib—MAP2K2—respiratory system—allergic rhinitis	0.00106	0.0038	CbGeAlD
Bosutinib—CAMK2G—eye—allergic rhinitis	0.00106	0.0038	CbGeAlD
Bosutinib—BMX—lung—allergic rhinitis	0.00106	0.0038	CbGeAlD
Bosutinib—CLK3—lung—allergic rhinitis	0.00106	0.0038	CbGeAlD
Bosutinib—DSTYK—lung—allergic rhinitis	0.00106	0.0038	CbGeAlD
Bosutinib—STK36—bronchus—allergic rhinitis	0.00106	0.0038	CbGeAlD
Bosutinib—EPHB3—bronchus—allergic rhinitis	0.00106	0.0038	CbGeAlD
Bosutinib—CASK—lung—allergic rhinitis	0.00104	0.00371	CbGeAlD
Bosutinib—PTK2—respiratory system—allergic rhinitis	0.00104	0.0037	CbGeAlD
Bosutinib—TBK1—respiratory system—allergic rhinitis	0.00104	0.0037	CbGeAlD
Bosutinib—BMPR2—skin of body—allergic rhinitis	0.00103	0.00369	CbGeAlD
Bosutinib—MAP4K4—bronchus—allergic rhinitis	0.00103	0.00368	CbGeAlD
Bosutinib—EIF2AK1—lung—allergic rhinitis	0.00103	0.00367	CbGeAlD
Bosutinib—BCR—bronchus—allergic rhinitis	0.00102	0.00366	CbGeAlD
Bosutinib—SRMS—lung—allergic rhinitis	0.00102	0.00363	CbGeAlD
Bosutinib—MAP3K12—bronchus—allergic rhinitis	0.00102	0.00363	CbGeAlD
Bosutinib—MAP2K1—epithelium—allergic rhinitis	0.00101	0.00361	CbGeAlD
Bosutinib—TXK—lung—allergic rhinitis	0.00101	0.0036	CbGeAlD
Bosutinib—FES—lung—allergic rhinitis	0.000997	0.00356	CbGeAlD
Bosutinib—VRK2—lung—allergic rhinitis	0.000997	0.00356	CbGeAlD
Bosutinib—RPS6KB1—respiratory system—allergic rhinitis	0.000996	0.00356	CbGeAlD
Bosutinib—FGR—respiratory system—allergic rhinitis	0.00099	0.00354	CbGeAlD
Bosutinib—CSK—bronchus—allergic rhinitis	0.000989	0.00353	CbGeAlD
Bosutinib—AXL—respiratory system—allergic rhinitis	0.000986	0.00352	CbGeAlD
Bosutinib—CSNK1A1—bronchus—allergic rhinitis	0.000982	0.00351	CbGeAlD
Bosutinib—TNIK—lung—allergic rhinitis	0.000977	0.00349	CbGeAlD
Bosutinib—SYK—lung—allergic rhinitis	0.000977	0.00349	CbGeAlD
Bosutinib—HCK—bronchus—allergic rhinitis	0.000976	0.00349	CbGeAlD
Bosutinib—CLK1—bronchus—allergic rhinitis	0.000976	0.00349	CbGeAlD
Bosutinib—ULK3—eye—allergic rhinitis	0.000973	0.00348	CbGeAlD
Bosutinib—CDK2—lung—allergic rhinitis	0.000968	0.00346	CbGeAlD
Bosutinib—MAP2K1—skin of body—allergic rhinitis	0.000961	0.00343	CbGeAlD
Bosutinib—STK35—skin of body—allergic rhinitis	0.000961	0.00343	CbGeAlD
Bosutinib—STK26—lung—allergic rhinitis	0.000959	0.00343	CbGeAlD
Bosutinib—BMP2K—bronchus—allergic rhinitis	0.000958	0.00342	CbGeAlD
Bosutinib—CSK—skin of body—allergic rhinitis	0.000955	0.00341	CbGeAlD
Bosutinib—STK36—trachea—allergic rhinitis	0.000954	0.00341	CbGeAlD
Bosutinib—EPHB3—trachea—allergic rhinitis	0.000954	0.00341	CbGeAlD
Bosutinib—CSNK1A1—skin of body—allergic rhinitis	0.000949	0.00339	CbGeAlD
Bosutinib—TBK1—eye—allergic rhinitis	0.000946	0.00338	CbGeAlD
Bosutinib—EPHB4—respiratory system—allergic rhinitis	0.000942	0.00337	CbGeAlD
Bosutinib—CHEK2—lung—allergic rhinitis	0.000926	0.00331	CbGeAlD
Bosutinib—MAP4K4—trachea—allergic rhinitis	0.000925	0.00331	CbGeAlD
Bosutinib—EPHA2—respiratory system—allergic rhinitis	0.000924	0.0033	CbGeAlD
Bosutinib—FYN—respiratory system—allergic rhinitis	0.000923	0.0033	CbGeAlD
Bosutinib—DMPK—lung—allergic rhinitis	0.000919	0.00328	CbGeAlD
Bosutinib—WEE1—lung—allergic rhinitis	0.000919	0.00328	CbGeAlD
Bosutinib—BCR—trachea—allergic rhinitis	0.000919	0.00328	CbGeAlD
Bosutinib—NUAK2—trachea—allergic rhinitis	0.000919	0.00328	CbGeAlD
Bosutinib—CSNK1E—bronchus—allergic rhinitis	0.00091	0.00325	CbGeAlD
Bosutinib—RPS6KB1—eye—allergic rhinitis	0.00091	0.00325	CbGeAlD
Bosutinib—AXL—eye—allergic rhinitis	0.000901	0.00322	CbGeAlD
Bosutinib—SIK1—bronchus—allergic rhinitis	0.000896	0.0032	CbGeAlD
Bosutinib—IRAK4—bronchus—allergic rhinitis	0.000896	0.0032	CbGeAlD
Bosutinib—ERBB3—epithelium—allergic rhinitis	0.000892	0.00319	CbGeAlD
Bosutinib—CSK—trachea—allergic rhinitis	0.000888	0.00317	CbGeAlD
Bosutinib—EPHA4—bronchus—allergic rhinitis	0.000887	0.00317	CbGeAlD
Bosutinib—CSNK1A1—trachea—allergic rhinitis	0.000882	0.00315	CbGeAlD
Bosutinib—CSNK1E—skin of body—allergic rhinitis	0.000879	0.00314	CbGeAlD
Bosutinib—STK25—lung—allergic rhinitis	0.000877	0.00314	CbGeAlD
Bosutinib—HCK—trachea—allergic rhinitis	0.000876	0.00313	CbGeAlD
Bosutinib—CLK1—trachea—allergic rhinitis	0.000876	0.00313	CbGeAlD
Bosutinib—ULK3—bronchus—allergic rhinitis	0.000876	0.00313	CbGeAlD
Bosutinib—MAP2K2—bronchus—allergic rhinitis	0.000876	0.00313	CbGeAlD
Bosutinib—EPHA3—lung—allergic rhinitis	0.000871	0.00311	CbGeAlD
Bosutinib—SIK1—skin of body—allergic rhinitis	0.000866	0.00309	CbGeAlD
Bosutinib—PTK2—epithelium—allergic rhinitis	0.000865	0.00309	CbGeAlD
Bosutinib—MAP3K7—bronchus—allergic rhinitis	0.000862	0.00308	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Flunisolide—allergic rhinitis	0.000862	0.113	CbGdCrCtD
Bosutinib—PLK2—lung—allergic rhinitis	0.000853	0.00305	CbGeAlD
Bosutinib—PTK2—bronchus—allergic rhinitis	0.000852	0.00304	CbGeAlD
Bosutinib—TBK1—bronchus—allergic rhinitis	0.000852	0.00304	CbGeAlD
Bosutinib—ERBB3—skin of body—allergic rhinitis	0.000848	0.00303	CbGeAlD
Bosutinib—SIK3—lung—allergic rhinitis	0.000847	0.00303	CbGeAlD
Bosutinib—MAP2K2—skin of body—allergic rhinitis	0.000846	0.00302	CbGeAlD
Bosutinib—IRAK1—bronchus—allergic rhinitis	0.000835	0.00298	CbGeAlD
Bosutinib—YES1—respiratory system—allergic rhinitis	0.000833	0.00298	CbGeAlD
Bosutinib—RPS6KB1—epithelium—allergic rhinitis	0.000832	0.00297	CbGeAlD
Bosutinib—STK10—respiratory system—allergic rhinitis	0.000825	0.00295	CbGeAlD
Bosutinib—PTK2—skin of body—allergic rhinitis	0.000823	0.00294	CbGeAlD
Bosutinib—TAOK3—respiratory system—allergic rhinitis	0.000822	0.00294	CbGeAlD
Bosutinib—RPS6KB1—bronchus—allergic rhinitis	0.00082	0.00293	CbGeAlD
Bosutinib—CSNK1E—trachea—allergic rhinitis	0.000817	0.00292	CbGeAlD
Bosutinib—STK4—lung—allergic rhinitis	0.000816	0.00291	CbGeAlD
Bosutinib—LCK—bronchus—allergic rhinitis	0.000815	0.00291	CbGeAlD
Bosutinib—CAMK1D—lung—allergic rhinitis	0.000806	0.00288	CbGeAlD
Bosutinib—IRAK4—trachea—allergic rhinitis	0.000805	0.00288	CbGeAlD
Bosutinib—SRC—respiratory system—allergic rhinitis	0.000801	0.00286	CbGeAlD
Bosutinib—STK24—lung—allergic rhinitis	0.000797	0.00285	CbGeAlD
Bosutinib—EPHA4—trachea—allergic rhinitis	0.000797	0.00285	CbGeAlD
Bosutinib—ERBB3—trachea—allergic rhinitis	0.000789	0.00282	CbGeAlD
Bosutinib—EPHB4—epithelium—allergic rhinitis	0.000787	0.00281	CbGeAlD
Bosutinib—ULK3—trachea—allergic rhinitis	0.000787	0.00281	CbGeAlD
Bosutinib—AXL—skin of body—allergic rhinitis	0.000784	0.0028	CbGeAlD
Bosutinib—SLK—bronchus—allergic rhinitis	0.000781	0.00279	CbGeAlD
Bosutinib—EPHB4—bronchus—allergic rhinitis	0.000775	0.00277	CbGeAlD
Bosutinib—MAP3K7—trachea—allergic rhinitis	0.000774	0.00277	CbGeAlD
Bosutinib—EPHA2—epithelium—allergic rhinitis	0.000772	0.00276	CbGeAlD
Bosutinib—FER—lung—allergic rhinitis	0.000771	0.00275	CbGeAlD
Bosutinib—ALK—lung—allergic rhinitis	0.000771	0.00275	CbGeAlD
Bosutinib—TBK1—trachea—allergic rhinitis	0.000765	0.00273	CbGeAlD
Bosutinib—PTK2—trachea—allergic rhinitis	0.000765	0.00273	CbGeAlD
Bosutinib—YES1—eye—allergic rhinitis	0.000761	0.00272	CbGeAlD
Bosutinib—EPHA2—bronchus—allergic rhinitis	0.000761	0.00272	CbGeAlD
Bosutinib—FYN—bronchus—allergic rhinitis	0.000759	0.00271	CbGeAlD
Bosutinib—MAP4K1—lung—allergic rhinitis	0.000755	0.0027	CbGeAlD
Bosutinib—MAP3K19—lung—allergic rhinitis	0.000755	0.0027	CbGeAlD
Bosutinib—BTK—lung—allergic rhinitis	0.000752	0.00269	CbGeAlD
Bosutinib—TAOK3—eye—allergic rhinitis	0.000751	0.00268	CbGeAlD
Bosutinib—MAP3K3—bronchus—allergic rhinitis	0.000742	0.00265	CbGeAlD
Bosutinib—MAP4K5—bronchus—allergic rhinitis	0.000742	0.00265	CbGeAlD
Bosutinib—TNK2—lung—allergic rhinitis	0.000741	0.00265	CbGeAlD
Bosutinib—RPS6KB1—trachea—allergic rhinitis	0.000736	0.00263	CbGeAlD
Bosutinib—FYN—skin of body—allergic rhinitis	0.000733	0.00262	CbGeAlD
Bosutinib—SRC—eye—allergic rhinitis	0.000732	0.00262	CbGeAlD
Bosutinib—LCK—trachea—allergic rhinitis	0.000732	0.00261	CbGeAlD
Bosutinib—MAP4K2—lung—allergic rhinitis	0.00073	0.00261	CbGeAlD
Bosutinib—AXL—trachea—allergic rhinitis	0.000729	0.0026	CbGeAlD
Bosutinib—ERBB4—lung—allergic rhinitis	0.00072	0.00257	CbGeAlD
Bosutinib—STK3—lung—allergic rhinitis	0.00072	0.00257	CbGeAlD
Bosutinib—CSF1R—respiratory system—allergic rhinitis	0.000719	0.00257	CbGeAlD
Bosutinib—MAP3K3—skin of body—allergic rhinitis	0.000717	0.00256	CbGeAlD
Bosutinib—ROCK1—lung—allergic rhinitis	0.000711	0.00254	CbGeAlD
Bosutinib—SLK—trachea—allergic rhinitis	0.000701	0.00251	CbGeAlD
Bosutinib—EPHB4—trachea—allergic rhinitis	0.000696	0.00249	CbGeAlD
Bosutinib—BMPR2—lung—allergic rhinitis	0.000691	0.00247	CbGeAlD
Bosutinib—YES1—bronchus—allergic rhinitis	0.000685	0.00245	CbGeAlD
Bosutinib—EPHB3—lung—allergic rhinitis	0.000685	0.00245	CbGeAlD
Bosutinib—STK36—lung—allergic rhinitis	0.000685	0.00245	CbGeAlD
Bosutinib—EPHA2—trachea—allergic rhinitis	0.000683	0.00244	CbGeAlD
Bosutinib—FYN—trachea—allergic rhinitis	0.000682	0.00244	CbGeAlD
Bosutinib—STK10—bronchus—allergic rhinitis	0.000679	0.00243	CbGeAlD
Bosutinib—MERTK—lung—allergic rhinitis	0.000677	0.00242	CbGeAlD
Bosutinib—TAOK3—bronchus—allergic rhinitis	0.000677	0.00242	CbGeAlD
Bosutinib—PTK2B—Carbinoxamine—Diphenhydramine—allergic rhinitis	0.000675	0.0883	CbGdCrCtD
Bosutinib—SRC—epithelium—allergic rhinitis	0.00067	0.00239	CbGeAlD
Bosutinib—MAP3K3—trachea—allergic rhinitis	0.000666	0.00238	CbGeAlD
Bosutinib—MAP4K5—trachea—allergic rhinitis	0.000666	0.00238	CbGeAlD
Bosutinib—MAP4K4—lung—allergic rhinitis	0.000665	0.00238	CbGeAlD
Bosutinib—NUAK2—lung—allergic rhinitis	0.00066	0.00236	CbGeAlD
Bosutinib—BCR—lung—allergic rhinitis	0.00066	0.00236	CbGeAlD
Bosutinib—CSF1R—eye—allergic rhinitis	0.000657	0.00235	CbGeAlD
Bosutinib—MAP3K12—lung—allergic rhinitis	0.000655	0.00234	CbGeAlD
Bosutinib—STK35—lung—allergic rhinitis	0.000642	0.00229	CbGeAlD
Bosutinib—MAP2K1—lung—allergic rhinitis	0.000642	0.00229	CbGeAlD
Bosutinib—CSK—lung—allergic rhinitis	0.000638	0.00228	CbGeAlD
Bosutinib—PDGFRB—respiratory system—allergic rhinitis	0.000638	0.00228	CbGeAlD
Bosutinib—SRC—skin of body—allergic rhinitis	0.000637	0.00228	CbGeAlD
Bosutinib—CSNK1A1—lung—allergic rhinitis	0.000634	0.00226	CbGeAlD
Bosutinib—HCK—lung—allergic rhinitis	0.00063	0.00225	CbGeAlD
Bosutinib—CLK1—lung—allergic rhinitis	0.00063	0.00225	CbGeAlD
Bosutinib—ABL2—lung—allergic rhinitis	0.000626	0.00224	CbGeAlD
Bosutinib—CAMK2G—lung—allergic rhinitis	0.000618	0.00221	CbGeAlD
Bosutinib—BMP2K—lung—allergic rhinitis	0.000618	0.00221	CbGeAlD
Bosutinib—YES1—trachea—allergic rhinitis	0.000615	0.0022	CbGeAlD
Bosutinib—LRRK2—lung—allergic rhinitis	0.000613	0.00219	CbGeAlD
Bosutinib—EGFR—lung—allergic rhinitis	0.000611	0.00218	CbGeAlD
Bosutinib—TAOK3—trachea—allergic rhinitis	0.000608	0.00217	CbGeAlD
Bosutinib—MAP2K5—bronchus—allergic rhinitis	0.000607	0.00217	CbGeAlD
Bosutinib—PTK2B—lung—allergic rhinitis	0.000597	0.00213	CbGeAlD
Bosutinib—CSF1R—bronchus—allergic rhinitis	0.000592	0.00212	CbGeAlD
Bosutinib—CSNK1E—lung—allergic rhinitis	0.000587	0.0021	CbGeAlD
Bosutinib—PDGFRB—eye—allergic rhinitis	0.000583	0.00208	CbGeAlD
Bosutinib—SIK1—lung—allergic rhinitis	0.000578	0.00207	CbGeAlD
Bosutinib—IRAK4—lung—allergic rhinitis	0.000578	0.00207	CbGeAlD
Bosutinib—EPHA4—lung—allergic rhinitis	0.000572	0.00205	CbGeAlD
Bosutinib—CSF1R—skin of body—allergic rhinitis	0.000572	0.00204	CbGeAlD
Bosutinib—ABL1—respiratory system—allergic rhinitis	0.000569	0.00203	CbGeAlD
Bosutinib—ERBB3—lung—allergic rhinitis	0.000567	0.00203	CbGeAlD
Bosutinib—MAP2K2—lung—allergic rhinitis	0.000565	0.00202	CbGeAlD
Bosutinib—ULK3—lung—allergic rhinitis	0.000565	0.00202	CbGeAlD
Bosutinib—MAP3K2—lung—allergic rhinitis	0.000561	0.00201	CbGeAlD
Bosutinib—MAP3K7—lung—allergic rhinitis	0.000556	0.00199	CbGeAlD
Bosutinib—PLK2—Levonorgestrel—Hydrocortisone—allergic rhinitis	0.000551	0.0721	CbGdCrCtD
Bosutinib—PTK2—lung—allergic rhinitis	0.00055	0.00196	CbGeAlD
Bosutinib—TBK1—lung—allergic rhinitis	0.00055	0.00196	CbGeAlD
Bosutinib—MAP2K5—trachea—allergic rhinitis	0.000545	0.00195	CbGeAlD
Bosutinib—IRAK1—lung—allergic rhinitis	0.000539	0.00193	CbGeAlD
Bosutinib—PDGFRB—epithelium—allergic rhinitis	0.000533	0.0019	CbGeAlD
Bosutinib—CSF1R—trachea—allergic rhinitis	0.000532	0.0019	CbGeAlD
Bosutinib—MAP4K4—Testosterone Propionate—Hydrocortisone—allergic rhinitis	0.000531	0.0695	CbGdCrCtD
Bosutinib—RPS6KB1—lung—allergic rhinitis	0.000529	0.00189	CbGeAlD
Bosutinib—FGR—lung—allergic rhinitis	0.000526	0.00188	CbGeAlD
Bosutinib—LCK—lung—allergic rhinitis	0.000526	0.00188	CbGeAlD
Bosutinib—PDGFRB—bronchus—allergic rhinitis	0.000525	0.00188	CbGeAlD
Bosutinib—AXL—lung—allergic rhinitis	0.000523	0.00187	CbGeAlD
Bosutinib—ABL1—eye—allergic rhinitis	0.000519	0.00186	CbGeAlD
Bosutinib—PDGFRB—skin of body—allergic rhinitis	0.000507	0.00181	CbGeAlD
Bosutinib—SLK—lung—allergic rhinitis	0.000504	0.0018	CbGeAlD
Bosutinib—EPHB4—lung—allergic rhinitis	0.0005	0.00179	CbGeAlD
Bosutinib—EPHA2—lung—allergic rhinitis	0.000491	0.00175	CbGeAlD
Bosutinib—FYN—lung—allergic rhinitis	0.00049	0.00175	CbGeAlD
Bosutinib—Dyspnoea—Flunisolide—allergic rhinitis	0.000486	0.00176	CcSEcCtD
Bosutinib—Feeling abnormal—Loratadine—allergic rhinitis	0.000485	0.00175	CcSEcCtD
Bosutinib—Myalgia—Montelukast—allergic rhinitis	0.000485	0.00175	CcSEcCtD
Bosutinib—Arthralgia—Montelukast—allergic rhinitis	0.000485	0.00175	CcSEcCtD
Bosutinib—Rash—Diphenhydramine—allergic rhinitis	0.000482	0.00174	CcSEcCtD
Bosutinib—Rash—Dimenhydrinate—allergic rhinitis	0.000482	0.00174	CcSEcCtD
Bosutinib—Decreased appetite—Cetirizine—allergic rhinitis	0.000482	0.00174	CcSEcCtD
Bosutinib—Dermatitis—Diphenhydramine—allergic rhinitis	0.000482	0.00174	CcSEcCtD
Bosutinib—Dermatitis—Dimenhydrinate—allergic rhinitis	0.000482	0.00174	CcSEcCtD
Bosutinib—Gastrointestinal pain—Loratadine—allergic rhinitis	0.000482	0.00174	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.000482	0.00174	CcSEcCtD
Bosutinib—Headache—Diphenhydramine—allergic rhinitis	0.000479	0.00173	CcSEcCtD
Bosutinib—Headache—Dimenhydrinate—allergic rhinitis	0.000479	0.00173	CcSEcCtD
Bosutinib—MAP3K3—lung—allergic rhinitis	0.000479	0.00171	CbGeAlD
Bosutinib—MAP4K5—lung—allergic rhinitis	0.000479	0.00171	CbGeAlD
Bosutinib—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000479	0.00173	CcSEcCtD
Bosutinib—Fatigue—Cetirizine—allergic rhinitis	0.000478	0.00173	CcSEcCtD
Bosutinib—Pain—Cetirizine—allergic rhinitis	0.000474	0.00171	CcSEcCtD
Bosutinib—Decreased appetite—Flunisolide—allergic rhinitis	0.000474	0.00171	CcSEcCtD
Bosutinib—PDGFRB—trachea—allergic rhinitis	0.000471	0.00168	CbGeAlD
Bosutinib—Fatigue—Flunisolide—allergic rhinitis	0.00047	0.0017	CcSEcCtD
Bosutinib—ABL1—bronchus—allergic rhinitis	0.000468	0.00167	CbGeAlD
Bosutinib—Abdominal pain upper—Hydrocortisone—allergic rhinitis	0.000466	0.00169	CcSEcCtD
Bosutinib—Pain—Flunisolide—allergic rhinitis	0.000466	0.00168	CcSEcCtD
Bosutinib—Abdominal pain—Loratadine—allergic rhinitis	0.000466	0.00168	CcSEcCtD
Bosutinib—Body temperature increased—Loratadine—allergic rhinitis	0.000466	0.00168	CcSEcCtD
Bosutinib—Anaphylactic shock—Montelukast—allergic rhinitis	0.000465	0.00168	CcSEcCtD
Bosutinib—Oedema—Montelukast—allergic rhinitis	0.000465	0.00168	CcSEcCtD
Bosutinib—Nausea—Olopatadine—allergic rhinitis	0.000464	0.00168	CcSEcCtD
Bosutinib—Infection—Montelukast—allergic rhinitis	0.000462	0.00167	CcSEcCtD
Bosutinib—Feeling abnormal—Cetirizine—allergic rhinitis	0.000457	0.00165	CcSEcCtD
Bosutinib—Nervous system disorder—Montelukast—allergic rhinitis	0.000456	0.00165	CcSEcCtD
Bosutinib—Thrombocytopenia—Montelukast—allergic rhinitis	0.000455	0.00164	CcSEcCtD
Bosutinib—Nausea—Diphenhydramine—allergic rhinitis	0.000454	0.00164	CcSEcCtD
Bosutinib—Nausea—Dimenhydrinate—allergic rhinitis	0.000454	0.00164	CcSEcCtD
Bosutinib—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.000453	0.00164	CcSEcCtD
Bosutinib—ABL1—skin of body—allergic rhinitis	0.000452	0.00161	CbGeAlD
Bosutinib—Skin disorder—Montelukast—allergic rhinitis	0.000451	0.00163	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.00045	0.00163	CcSEcCtD
Bosutinib—Feeling abnormal—Flunisolide—allergic rhinitis	0.000449	0.00162	CcSEcCtD
Bosutinib—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.000446	0.00161	CcSEcCtD
Bosutinib—YES1—lung—allergic rhinitis	0.000442	0.00158	CbGeAlD
Bosutinib—Urticaria—Cetirizine—allergic rhinitis	0.00044	0.00159	CcSEcCtD
Bosutinib—STK10—lung—allergic rhinitis	0.000438	0.00157	CbGeAlD
Bosutinib—Body temperature increased—Cetirizine—allergic rhinitis	0.000438	0.00158	CcSEcCtD
Bosutinib—Abdominal pain—Cetirizine—allergic rhinitis	0.000438	0.00158	CcSEcCtD
Bosutinib—TAOK3—lung—allergic rhinitis	0.000437	0.00156	CbGeAlD
Bosutinib—Urticaria—Flunisolide—allergic rhinitis	0.000433	0.00156	CcSEcCtD
Bosutinib—Abdominal pain—Flunisolide—allergic rhinitis	0.000431	0.00156	CcSEcCtD
Bosutinib—Body temperature increased—Flunisolide—allergic rhinitis	0.000431	0.00156	CcSEcCtD
Bosutinib—SRC—lung—allergic rhinitis	0.000425	0.00152	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000423	0.00153	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000423	0.00153	CcSEcCtD
Bosutinib—Asthenia—Loratadine—allergic rhinitis	0.000423	0.00153	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Methylprednisolone—allergic rhinitis	0.000422	0.0552	CbGdCrCtD
Bosutinib—ABL1—trachea—allergic rhinitis	0.00042	0.0015	CbGeAlD
Bosutinib—Influenza—Triamcinolone—allergic rhinitis	0.000416	0.0015	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Dexamethasone—allergic rhinitis	0.000415	0.0543	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Betamethasone—allergic rhinitis	0.000415	0.0543	CbGdCrCtD
Bosutinib—Upper respiratory tract infection—Hydrocortisone—allergic rhinitis	0.00041	0.00148	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Triamcinolone—allergic rhinitis	0.000406	0.053	CbGdCrCtD
Bosutinib—Diarrhoea—Loratadine—allergic rhinitis	0.000403	0.00146	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000401	0.00145	CcSEcCtD
Bosutinib—Fatigue—Montelukast—allergic rhinitis	0.000401	0.00145	CcSEcCtD
Bosutinib—Bronchitis—Triamcinolone—allergic rhinitis	0.0004	0.00144	CcSEcCtD
Bosutinib—Asthenia—Cetirizine—allergic rhinitis	0.000398	0.00144	CcSEcCtD
Bosutinib—Pain—Montelukast—allergic rhinitis	0.000397	0.00144	CcSEcCtD
Bosutinib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000394	0.00142	CcSEcCtD
Bosutinib—Infestation—Hydrocortisone—allergic rhinitis	0.000394	0.00142	CcSEcCtD
Bosutinib—Pruritus—Cetirizine—allergic rhinitis	0.000392	0.00142	CcSEcCtD
Bosutinib—MAP2K5—lung—allergic rhinitis	0.000391	0.0014	CbGeAlD
Bosutinib—Asthenia—Flunisolide—allergic rhinitis	0.000391	0.00141	CcSEcCtD
Bosutinib—Dizziness—Loratadine—allergic rhinitis	0.00039	0.00141	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	0.000386	0.0014	CcSEcCtD
Bosutinib—Pruritus—Flunisolide—allergic rhinitis	0.000386	0.00139	CcSEcCtD
Bosutinib—CSF1R—lung—allergic rhinitis	0.000382	0.00136	CbGeAlD
Bosutinib—Gastrointestinal pain—Montelukast—allergic rhinitis	0.00038	0.00137	CcSEcCtD
Bosutinib—Diarrhoea—Cetirizine—allergic rhinitis	0.000379	0.00137	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Prednisolone—allergic rhinitis	0.000376	0.0491	CbGdCrCtD
Bosutinib—Vomiting—Loratadine—allergic rhinitis	0.000375	0.00135	CcSEcCtD
Bosutinib—Diarrhoea—Flunisolide—allergic rhinitis	0.000373	0.00135	CcSEcCtD
Bosutinib—Rash—Loratadine—allergic rhinitis	0.000371	0.00134	CcSEcCtD
Bosutinib—Dermatitis—Loratadine—allergic rhinitis	0.000371	0.00134	CcSEcCtD
Bosutinib—Infestation—Methylprednisolone—allergic rhinitis	0.00037	0.00134	CcSEcCtD
Bosutinib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.00037	0.00134	CcSEcCtD
Bosutinib—Urticaria—Montelukast—allergic rhinitis	0.000369	0.00133	CcSEcCtD
Bosutinib—Headache—Loratadine—allergic rhinitis	0.000369	0.00133	CcSEcCtD
Bosutinib—Abdominal pain—Montelukast—allergic rhinitis	0.000367	0.00133	CcSEcCtD
Bosutinib—Body temperature increased—Montelukast—allergic rhinitis	0.000367	0.00133	CcSEcCtD
Bosutinib—Dizziness—Cetirizine—allergic rhinitis	0.000367	0.00132	CcSEcCtD
Bosutinib—Dizziness—Flunisolide—allergic rhinitis	0.00036	0.0013	CcSEcCtD
Bosutinib—Vomiting—Cetirizine—allergic rhinitis	0.000352	0.00127	CcSEcCtD
Bosutinib—Nausea—Loratadine—allergic rhinitis	0.00035	0.00126	CcSEcCtD
Bosutinib—Rash—Cetirizine—allergic rhinitis	0.000349	0.00126	CcSEcCtD
Bosutinib—Dermatitis—Cetirizine—allergic rhinitis	0.000349	0.00126	CcSEcCtD
Bosutinib—Headache—Cetirizine—allergic rhinitis	0.000347	0.00125	CcSEcCtD
Bosutinib—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000347	0.00125	CcSEcCtD
Bosutinib—Vomiting—Flunisolide—allergic rhinitis	0.000347	0.00125	CcSEcCtD
Bosutinib—Rash—Flunisolide—allergic rhinitis	0.000344	0.00124	CcSEcCtD
Bosutinib—Dermatitis—Flunisolide—allergic rhinitis	0.000343	0.00124	CcSEcCtD
Bosutinib—Headache—Flunisolide—allergic rhinitis	0.000341	0.00123	CcSEcCtD
Bosutinib—PDGFRB—lung—allergic rhinitis	0.000339	0.00121	CbGeAlD
Bosutinib—Asthenia—Montelukast—allergic rhinitis	0.000333	0.00121	CcSEcCtD
Bosutinib—Nausea—Cetirizine—allergic rhinitis	0.000329	0.00119	CcSEcCtD
Bosutinib—Pruritus—Montelukast—allergic rhinitis	0.000329	0.00119	CcSEcCtD
Bosutinib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000326	0.00118	CcSEcCtD
Bosutinib—Nausea—Flunisolide—allergic rhinitis	0.000324	0.00117	CcSEcCtD
Bosutinib—Immune system disorder—Hydrocortisone—allergic rhinitis	0.000319	0.00115	CcSEcCtD
Bosutinib—Diarrhoea—Montelukast—allergic rhinitis	0.000318	0.00115	CcSEcCtD
Bosutinib—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000308	0.00111	CcSEcCtD
Bosutinib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000308	0.00111	CcSEcCtD
Bosutinib—Dizziness—Montelukast—allergic rhinitis	0.000307	0.00111	CcSEcCtD
Bosutinib—ABL1—lung—allergic rhinitis	0.000302	0.00108	CbGeAlD
Bosutinib—Immune system disorder—Methylprednisolone—allergic rhinitis	0.0003	0.00108	CcSEcCtD
Bosutinib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000299	0.00108	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Flunisolide—allergic rhinitis	0.000298	0.039	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Flunisolide—allergic rhinitis	0.000298	0.039	CbGdCrCtD
Bosutinib—Vomiting—Montelukast—allergic rhinitis	0.000296	0.00107	CcSEcCtD
Bosutinib—Rash—Montelukast—allergic rhinitis	0.000293	0.00106	CcSEcCtD
Bosutinib—Dermatitis—Montelukast—allergic rhinitis	0.000293	0.00106	CcSEcCtD
Bosutinib—Ill-defined disorder—Prednisolone—allergic rhinitis	0.000292	0.00106	CcSEcCtD
Bosutinib—Headache—Montelukast—allergic rhinitis	0.000291	0.00105	CcSEcCtD
Bosutinib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000289	0.00104	CcSEcCtD
Bosutinib—Ill-defined disorder—Hydrocortisone—allergic rhinitis	0.000285	0.00103	CcSEcCtD
Bosutinib—Malaise—Prednisolone—allergic rhinitis	0.000284	0.00103	CcSEcCtD
Bosutinib—Dysgeusia—Triamcinolone—allergic rhinitis	0.000284	0.00102	CcSEcCtD
Bosutinib—Back pain—Triamcinolone—allergic rhinitis	0.00028	0.00101	CcSEcCtD
Bosutinib—Malaise—Hydrocortisone—allergic rhinitis	0.000277	0.001	CcSEcCtD
Bosutinib—Nausea—Montelukast—allergic rhinitis	0.000276	0.000998	CcSEcCtD
Bosutinib—Ill-defined disorder—Triamcinolone—allergic rhinitis	0.000269	0.000971	CcSEcCtD
Bosutinib—Ill-defined disorder—Methylprednisolone—allergic rhinitis	0.000268	0.000969	CcSEcCtD
Bosutinib—Discomfort—Prednisolone—allergic rhinitis	0.000265	0.000957	CcSEcCtD
Bosutinib—Myalgia—Hydrocortisone—allergic rhinitis	0.000262	0.000946	CcSEcCtD
Bosutinib—Malaise—Triamcinolone—allergic rhinitis	0.000261	0.000944	CcSEcCtD
Bosutinib—Malaise—Methylprednisolone—allergic rhinitis	0.000261	0.000942	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.00026	0.00094	CcSEcCtD
Bosutinib—Discomfort—Hydrocortisone—allergic rhinitis	0.000259	0.000935	CcSEcCtD
Bosutinib—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000257	0.000929	CcSEcCtD
Bosutinib—Oedema—Prednisolone—allergic rhinitis	0.000257	0.000929	CcSEcCtD
Bosutinib—PKMYT1—Danazol—Hydrocortisone—allergic rhinitis	0.000254	0.0332	CbGdCrCtD
Bosutinib—Cough—Triamcinolone—allergic rhinitis	0.000253	0.000913	CcSEcCtD
Bosutinib—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.000251	0.000907	CcSEcCtD
Bosutinib—Oedema—Hydrocortisone—allergic rhinitis	0.000251	0.000907	CcSEcCtD
Bosutinib—Infection—Hydrocortisone—allergic rhinitis	0.000249	0.000901	CcSEcCtD
Bosutinib—Myalgia—Triamcinolone—allergic rhinitis	0.000247	0.000891	CcSEcCtD
Bosutinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000246	0.000889	CcSEcCtD
Bosutinib—Myalgia—Methylprednisolone—allergic rhinitis	0.000246	0.000889	CcSEcCtD
Bosutinib—Arthralgia—Methylprednisolone—allergic rhinitis	0.000246	0.000889	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000244	0.000883	CcSEcCtD
Bosutinib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000244	0.000881	CcSEcCtD
Bosutinib—Ill-defined disorder—Dexamethasone—allergic rhinitis	0.000244	0.000881	CcSEcCtD
Bosutinib—Ill-defined disorder—Betamethasone—allergic rhinitis	0.000244	0.000881	CcSEcCtD
Bosutinib—Discomfort—Triamcinolone—allergic rhinitis	0.000244	0.00088	CcSEcCtD
Bosutinib—Discomfort—Methylprednisolone—allergic rhinitis	0.000243	0.000878	CcSEcCtD
Bosutinib—CSNK1E—Danazol—Hydrocortisone—allergic rhinitis	0.000242	0.0316	CbGdCrCtD
Bosutinib—Malaise—Dexamethasone—allergic rhinitis	0.000237	0.000856	CcSEcCtD
Bosutinib—Malaise—Betamethasone—allergic rhinitis	0.000237	0.000856	CcSEcCtD
Bosutinib—Anaphylactic shock—Triamcinolone—allergic rhinitis	0.000236	0.000854	CcSEcCtD
Bosutinib—Oedema—Triamcinolone—allergic rhinitis	0.000236	0.000854	CcSEcCtD
Bosutinib—Anaphylactic shock—Methylprednisolone—allergic rhinitis	0.000236	0.000852	CcSEcCtD
Bosutinib—Infection—Triamcinolone—allergic rhinitis	0.000235	0.000848	CcSEcCtD
Bosutinib—Infection—Methylprednisolone—allergic rhinitis	0.000234	0.000847	CcSEcCtD
Bosutinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000231	0.000836	CcSEcCtD
Bosutinib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000229	0.000828	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000229	0.000826	CcSEcCtD
Bosutinib—Myalgia—Dexamethasone—allergic rhinitis	0.000224	0.000808	CcSEcCtD
Bosutinib—Myalgia—Betamethasone—allergic rhinitis	0.000224	0.000808	CcSEcCtD
Bosutinib—Discomfort—Betamethasone—allergic rhinitis	0.000221	0.000799	CcSEcCtD
Bosutinib—Discomfort—Dexamethasone—allergic rhinitis	0.000221	0.000799	CcSEcCtD
Bosutinib—Pain—Prednisolone—allergic rhinitis	0.00022	0.000794	CcSEcCtD
Bosutinib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000218	0.000788	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000217	0.000783	CcSEcCtD
Bosutinib—Fatigue—Hydrocortisone—allergic rhinitis	0.000216	0.000782	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000215	0.000778	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000215	0.000776	CcSEcCtD
Bosutinib—Pain—Hydrocortisone—allergic rhinitis	0.000215	0.000776	CcSEcCtD
Bosutinib—Anaphylactic shock—Betamethasone—allergic rhinitis	0.000214	0.000775	CcSEcCtD
Bosutinib—Anaphylactic shock—Dexamethasone—allergic rhinitis	0.000214	0.000775	CcSEcCtD
Bosutinib—Oedema—Dexamethasone—allergic rhinitis	0.000214	0.000775	CcSEcCtD
Bosutinib—Oedema—Betamethasone—allergic rhinitis	0.000214	0.000775	CcSEcCtD
Bosutinib—Infection—Betamethasone—allergic rhinitis	0.000213	0.00077	CcSEcCtD
Bosutinib—Infection—Dexamethasone—allergic rhinitis	0.000213	0.00077	CcSEcCtD
Bosutinib—Feeling abnormal—Prednisolone—allergic rhinitis	0.000212	0.000765	CcSEcCtD
Bosutinib—Dyspnoea—Triamcinolone—allergic rhinitis	0.000211	0.000761	CcSEcCtD
Bosutinib—Nervous system disorder—Betamethasone—allergic rhinitis	0.00021	0.00076	CcSEcCtD
Bosutinib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.00021	0.00076	CcSEcCtD
Bosutinib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.00021	0.000759	CcSEcCtD
Bosutinib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.00021	0.000759	CcSEcCtD
Bosutinib—Feeling abnormal—Hydrocortisone—allergic rhinitis	0.000207	0.000747	CcSEcCtD
Bosutinib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000205	0.000742	CcSEcCtD
Bosutinib—Urticaria—Prednisolone—allergic rhinitis	0.000204	0.000738	CcSEcCtD
Bosutinib—Fatigue—Triamcinolone—allergic rhinitis	0.000204	0.000736	CcSEcCtD
Bosutinib—Fatigue—Methylprednisolone—allergic rhinitis	0.000203	0.000735	CcSEcCtD
Bosutinib—Pain—Triamcinolone—allergic rhinitis	0.000202	0.00073	CcSEcCtD
Bosutinib—Urticaria—Hydrocortisone—allergic rhinitis	0.000199	0.000721	CcSEcCtD
Bosutinib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000198	0.000717	CcSEcCtD
Bosutinib—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000198	0.000717	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000195	0.000706	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000195	0.000706	CcSEcCtD
Bosutinib—Feeling abnormal—Triamcinolone—allergic rhinitis	0.000195	0.000704	CcSEcCtD
Bosutinib—Feeling abnormal—Methylprednisolone—allergic rhinitis	0.000194	0.000702	CcSEcCtD
Bosutinib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000193	0.000697	CcSEcCtD
Bosutinib—Urticaria—Triamcinolone—allergic rhinitis	0.000188	0.000678	CcSEcCtD
Bosutinib—Urticaria—Methylprednisolone—allergic rhinitis	0.000187	0.000677	CcSEcCtD
Bosutinib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000187	0.000675	CcSEcCtD
Bosutinib—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000186	0.000674	CcSEcCtD
Bosutinib—Decreased appetite—Betamethasone—allergic rhinitis	0.000186	0.000674	CcSEcCtD
Bosutinib—Decreased appetite—Dexamethasone—allergic rhinitis	0.000186	0.000674	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000185	0.000669	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000185	0.000669	CcSEcCtD
Bosutinib—Fatigue—Betamethasone—allergic rhinitis	0.000185	0.000668	CcSEcCtD
Bosutinib—Fatigue—Dexamethasone—allergic rhinitis	0.000185	0.000668	CcSEcCtD
Bosutinib—Pain—Betamethasone—allergic rhinitis	0.000183	0.000663	CcSEcCtD
Bosutinib—Pain—Dexamethasone—allergic rhinitis	0.000183	0.000663	CcSEcCtD
Bosutinib—Asthenia—Hydrocortisone—allergic rhinitis	0.00018	0.000651	CcSEcCtD
Bosutinib—Pruritus—Hydrocortisone—allergic rhinitis	0.000178	0.000642	CcSEcCtD
Bosutinib—ABCB1—respiratory system—allergic rhinitis	0.000177	0.000632	CbGeAlD
Bosutinib—Feeling abnormal—Dexamethasone—allergic rhinitis	0.000177	0.000639	CcSEcCtD
Bosutinib—Feeling abnormal—Betamethasone—allergic rhinitis	0.000177	0.000639	CcSEcCtD
Bosutinib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000175	0.000634	CcSEcCtD
Bosutinib—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000175	0.000634	CcSEcCtD
Bosutinib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000172	0.000621	CcSEcCtD
Bosutinib—Urticaria—Betamethasone—allergic rhinitis	0.00017	0.000616	CcSEcCtD
Bosutinib—Urticaria—Dexamethasone—allergic rhinitis	0.00017	0.000616	CcSEcCtD
Bosutinib—Dizziness—Prednisolone—allergic rhinitis	0.00017	0.000614	CcSEcCtD
Bosutinib—Asthenia—Triamcinolone—allergic rhinitis	0.00017	0.000613	CcSEcCtD
Bosutinib—Body temperature increased—Betamethasone—allergic rhinitis	0.00017	0.000613	CcSEcCtD
Bosutinib—Body temperature increased—Dexamethasone—allergic rhinitis	0.00017	0.000613	CcSEcCtD
Bosutinib—Abdominal pain—Betamethasone—allergic rhinitis	0.00017	0.000613	CcSEcCtD
Bosutinib—Abdominal pain—Dexamethasone—allergic rhinitis	0.00017	0.000613	CcSEcCtD
Bosutinib—Asthenia—Methylprednisolone—allergic rhinitis	0.000169	0.000611	CcSEcCtD
Bosutinib—Pruritus—Triamcinolone—allergic rhinitis	0.000167	0.000604	CcSEcCtD
Bosutinib—Pruritus—Methylprednisolone—allergic rhinitis	0.000167	0.000603	CcSEcCtD
Bosutinib—Dizziness—Hydrocortisone—allergic rhinitis	0.000166	0.0006	CcSEcCtD
Bosutinib—Rash—Prednisolone—allergic rhinitis	0.000162	0.000586	CcSEcCtD
Bosutinib—Dermatitis—Prednisolone—allergic rhinitis	0.000162	0.000585	CcSEcCtD
Bosutinib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000161	0.000583	CcSEcCtD
Bosutinib—Headache—Prednisolone—allergic rhinitis	0.000161	0.000582	CcSEcCtD
Bosutinib—Vomiting—Hydrocortisone—allergic rhinitis	0.00016	0.000577	CcSEcCtD
Bosutinib—Rash—Hydrocortisone—allergic rhinitis	0.000158	0.000572	CcSEcCtD
Bosutinib—Dermatitis—Hydrocortisone—allergic rhinitis	0.000158	0.000571	CcSEcCtD
Bosutinib—Headache—Hydrocortisone—allergic rhinitis	0.000157	0.000568	CcSEcCtD
Bosutinib—Dizziness—Triamcinolone—allergic rhinitis	0.000156	0.000565	CcSEcCtD
Bosutinib—Dizziness—Methylprednisolone—allergic rhinitis	0.000156	0.000563	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Hydrocortisone—allergic rhinitis	0.000154	0.0202	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Hydrocortisone—allergic rhinitis	0.000154	0.0202	CbGdCrCtD
Bosutinib—Asthenia—Dexamethasone—allergic rhinitis	0.000154	0.000556	CcSEcCtD
Bosutinib—Asthenia—Betamethasone—allergic rhinitis	0.000154	0.000556	CcSEcCtD
Bosutinib—Nausea—Prednisolone—allergic rhinitis	0.000153	0.000552	CcSEcCtD
Bosutinib—Pruritus—Betamethasone—allergic rhinitis	0.000152	0.000548	CcSEcCtD
Bosutinib—Pruritus—Dexamethasone—allergic rhinitis	0.000152	0.000548	CcSEcCtD
Bosutinib—Vomiting—Triamcinolone—allergic rhinitis	0.00015	0.000543	CcSEcCtD
Bosutinib—Vomiting—Methylprednisolone—allergic rhinitis	0.00015	0.000542	CcSEcCtD
Bosutinib—Nausea—Hydrocortisone—allergic rhinitis	0.000149	0.000539	CcSEcCtD
Bosutinib—Rash—Triamcinolone—allergic rhinitis	0.000149	0.000538	CcSEcCtD
Bosutinib—CHEK2—Testosterone Propionate—Hydrocortisone—allergic rhinitis	0.000149	0.0195	CbGdCrCtD
Bosutinib—Dermatitis—Triamcinolone—allergic rhinitis	0.000149	0.000538	CcSEcCtD
Bosutinib—Rash—Methylprednisolone—allergic rhinitis	0.000149	0.000537	CcSEcCtD
Bosutinib—Dermatitis—Methylprednisolone—allergic rhinitis	0.000149	0.000537	CcSEcCtD
Bosutinib—Headache—Triamcinolone—allergic rhinitis	0.000148	0.000535	CcSEcCtD
Bosutinib—ABCB1—epithelium—allergic rhinitis	0.000148	0.000528	CbGeAlD
Bosutinib—Headache—Methylprednisolone—allergic rhinitis	0.000148	0.000534	CcSEcCtD
Bosutinib—Diarrhoea—Dexamethasone—allergic rhinitis	0.000147	0.00053	CcSEcCtD
Bosutinib—Diarrhoea—Betamethasone—allergic rhinitis	0.000147	0.00053	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Methylprednisolone—allergic rhinitis	0.000146	0.0191	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Methylprednisolone—allergic rhinitis	0.000146	0.0191	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Betamethasone—allergic rhinitis	0.000143	0.0188	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Dexamethasone—allergic rhinitis	0.000143	0.0188	CbGdCrCtD
Bosutinib—Dizziness—Betamethasone—allergic rhinitis	0.000142	0.000512	CcSEcCtD
Bosutinib—Dizziness—Dexamethasone—allergic rhinitis	0.000142	0.000512	CcSEcCtD
Bosutinib—Nausea—Triamcinolone—allergic rhinitis	0.00014	0.000507	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Triamcinolone—allergic rhinitis	0.00014	0.0183	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Triamcinolone—allergic rhinitis	0.00014	0.0183	CbGdCrCtD
Bosutinib—Nausea—Methylprednisolone—allergic rhinitis	0.00014	0.000506	CcSEcCtD
Bosutinib—Vomiting—Dexamethasone—allergic rhinitis	0.000136	0.000493	CcSEcCtD
Bosutinib—Vomiting—Betamethasone—allergic rhinitis	0.000136	0.000493	CcSEcCtD
Bosutinib—Rash—Betamethasone—allergic rhinitis	0.000135	0.000489	CcSEcCtD
Bosutinib—Rash—Dexamethasone—allergic rhinitis	0.000135	0.000489	CcSEcCtD
Bosutinib—Dermatitis—Betamethasone—allergic rhinitis	0.000135	0.000488	CcSEcCtD
Bosutinib—Dermatitis—Dexamethasone—allergic rhinitis	0.000135	0.000488	CcSEcCtD
Bosutinib—Headache—Betamethasone—allergic rhinitis	0.000134	0.000485	CcSEcCtD
Bosutinib—Headache—Dexamethasone—allergic rhinitis	0.000134	0.000485	CcSEcCtD
Bosutinib—ABCB1—trachea—allergic rhinitis	0.000131	0.000467	CbGeAlD
Bosutinib—CSNK1E—Dexamethasone—Prednisolone—allergic rhinitis	0.00013	0.017	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Prednisolone—allergic rhinitis	0.00013	0.017	CbGdCrCtD
Bosutinib—Nausea—Dexamethasone—allergic rhinitis	0.000127	0.00046	CcSEcCtD
Bosutinib—Nausea—Betamethasone—allergic rhinitis	0.000127	0.00046	CcSEcCtD
Bosutinib—CHEK2—Danazol—Hydrocortisone—allergic rhinitis	0.000124	0.0162	CbGdCrCtD
Bosutinib—CHEK2—Norethindrone—Hydrocortisone—allergic rhinitis	0.000112	0.0146	CbGdCrCtD
Bosutinib—ABCB1—lung—allergic rhinitis	9.39e-05	0.000335	CbGeAlD
Bosutinib—CHEK2—Levonorgestrel—Hydrocortisone—allergic rhinitis	8.88e-05	0.0116	CbGdCrCtD
Bosutinib—YES1—Adaptive Immune System—NFKB1—allergic rhinitis	2.29e-05	7.67e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HLA-DQB1—allergic rhinitis	2.29e-05	7.67e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—SMAD3—allergic rhinitis	2.28e-05	7.64e-05	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—TGFB1—allergic rhinitis	2.28e-05	7.64e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—NFKB1—allergic rhinitis	2.28e-05	7.63e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL11—allergic rhinitis	2.27e-05	7.6e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—NFKB1—allergic rhinitis	2.26e-05	7.57e-05	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—NFKB1—allergic rhinitis	2.26e-05	7.57e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—SMAD3—allergic rhinitis	2.25e-05	7.53e-05	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—TGFB1—allergic rhinitis	2.25e-05	7.53e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL5—allergic rhinitis	2.24e-05	7.51e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—HLA-DQB1—allergic rhinitis	2.24e-05	7.51e-05	CbGpPWpGaD
Bosutinib—PTK2—Hemostasis—TGFB1—allergic rhinitis	2.24e-05	7.49e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HLA-DQB1—allergic rhinitis	2.23e-05	7.47e-05	CbGpPWpGaD
Bosutinib—TBK1—Immune System—NFKB1—allergic rhinitis	2.23e-05	7.46e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—CD4—allergic rhinitis	2.23e-05	7.45e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—ICAM1—allergic rhinitis	2.23e-05	7.45e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—CD4—allergic rhinitis	2.21e-05	7.41e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—ICAM1—allergic rhinitis	2.21e-05	7.4e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—HLA-DQB1—allergic rhinitis	2.21e-05	7.39e-05	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—TGFB1—allergic rhinitis	2.21e-05	7.39e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HLA-DQB1—allergic rhinitis	2.2e-05	7.35e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—ICAM1—allergic rhinitis	2.19e-05	7.35e-05	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—TGFB1—allergic rhinitis	2.19e-05	7.33e-05	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—NFKB1—allergic rhinitis	2.19e-05	7.32e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—SMAD3—allergic rhinitis	2.17e-05	7.26e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—CD4—allergic rhinitis	2.16e-05	7.23e-05	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—NFKB1—allergic rhinitis	2.14e-05	7.15e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—NFKB1—allergic rhinitis	2.13e-05	7.13e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—CD4—allergic rhinitis	2.11e-05	7.06e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—NFKB1—allergic rhinitis	2.11e-05	7.06e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TAC1—allergic rhinitis	2.11e-05	7.06e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL5—allergic rhinitis	2.1e-05	7.03e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—SMAD3—allergic rhinitis	2.09e-05	6.99e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—SMAD3—allergic rhinitis	2.09e-05	6.99e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CD4—allergic rhinitis	2.08e-05	6.98e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CYSLTR1—allergic rhinitis	2.08e-05	6.97e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—ICAM1—allergic rhinitis	2.08e-05	6.97e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—NFKB1—allergic rhinitis	2.08e-05	6.95e-05	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—TGFB1—allergic rhinitis	2.08e-05	6.95e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—CD4—allergic rhinitis	2.06e-05	6.91e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TAC1—allergic rhinitis	2.06e-05	6.89e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—CD4—allergic rhinitis	2.05e-05	6.88e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CD4—allergic rhinitis	2.05e-05	6.87e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—NFKB1—allergic rhinitis	2.05e-05	6.85e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—CD4—allergic rhinitis	2.04e-05	6.84e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—CD4—allergic rhinitis	2.03e-05	6.8e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—CD4—allergic rhinitis	2.02e-05	6.78e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—CD4—allergic rhinitis	2.02e-05	6.77e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—NFKB1—allergic rhinitis	2.01e-05	6.74e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TAC1—allergic rhinitis	2.01e-05	6.74e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SMAD3—allergic rhinitis	2.01e-05	6.74e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL11—allergic rhinitis	2.01e-05	6.73e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—NFKB1—allergic rhinitis	2e-05	6.71e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—CD4—allergic rhinitis	2e-05	6.71e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—CD4—allergic rhinitis	2e-05	6.69e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—NFKB1—allergic rhinitis	1.99e-05	6.67e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—NFKB1—allergic rhinitis	1.99e-05	6.65e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—NFKB1—allergic rhinitis	1.98e-05	6.64e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TAC1—allergic rhinitis	1.98e-05	6.64e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CD4—allergic rhinitis	1.98e-05	6.64e-05	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—TGFB1—allergic rhinitis	1.98e-05	6.63e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—TGFB1—allergic rhinitis	1.98e-05	6.62e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—TGFB1—allergic rhinitis	1.98e-05	6.62e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—NFKB1—allergic rhinitis	1.97e-05	6.6e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TAC1—allergic rhinitis	1.97e-05	6.6e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—SMAD3—allergic rhinitis	1.97e-05	6.59e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—ICAM1—allergic rhinitis	1.96e-05	6.56e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL5—allergic rhinitis	1.96e-05	6.56e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—ICAM1—allergic rhinitis	1.96e-05	6.55e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CD4—allergic rhinitis	1.95e-05	6.53e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—CD4—allergic rhinitis	1.92e-05	6.44e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—SMAD3—allergic rhinitis	1.92e-05	6.43e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL5—allergic rhinitis	1.91e-05	6.4e-05	CbGpPWpGaD
Bosutinib—CSK—Disease—TGFB1—allergic rhinitis	1.91e-05	6.39e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HLA-DQB1—allergic rhinitis	1.91e-05	6.38e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—NFKB1—allergic rhinitis	1.91e-05	6.38e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—TGFB1—allergic rhinitis	1.9e-05	6.35e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL5—allergic rhinitis	1.87e-05	6.27e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—NFKB1—allergic rhinitis	1.86e-05	6.23e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—SMAD3—allergic rhinitis	1.85e-05	6.2e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	1.85e-05	6.19e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL5—allergic rhinitis	1.84e-05	6.17e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—SMAD3—allergic rhinitis	1.84e-05	6.17e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-DQB1—allergic rhinitis	1.84e-05	6.15e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CD4—allergic rhinitis	1.84e-05	6.15e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL5—allergic rhinitis	1.83e-05	6.14e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—NFKB1—allergic rhinitis	1.82e-05	6.08e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—NFKB1—allergic rhinitis	1.8e-05	6.01e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SMAD3—allergic rhinitis	1.79e-05	6e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—NFKB1—allergic rhinitis	1.78e-05	5.95e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—NFKB1—allergic rhinitis	1.77e-05	5.93e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—NFKB1—allergic rhinitis	1.77e-05	5.92e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SMAD3—allergic rhinitis	1.77e-05	5.92e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—TGFB1—allergic rhinitis	1.76e-05	5.88e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—CD4—allergic rhinitis	1.76e-05	5.88e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—NFKB1—allergic rhinitis	1.75e-05	5.86e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—NFKB1—allergic rhinitis	1.74e-05	5.84e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—NFKB1—allergic rhinitis	1.74e-05	5.83e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—NFKB1—allergic rhinitis	1.73e-05	5.78e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—NFKB1—allergic rhinitis	1.72e-05	5.76e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—NFKB1—allergic rhinitis	1.71e-05	5.73e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TAC1—allergic rhinitis	1.71e-05	5.73e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—ICAM1—allergic rhinitis	1.71e-05	5.73e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—NFKB1—allergic rhinitis	1.71e-05	5.72e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—CD4—allergic rhinitis	1.7e-05	5.68e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—NFKB1—allergic rhinitis	1.69e-05	5.67e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—CD4—allergic rhinitis	1.69e-05	5.66e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CD4—allergic rhinitis	1.69e-05	5.64e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—NFKB1—allergic rhinitis	1.68e-05	5.63e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—TGFB1—allergic rhinitis	1.68e-05	5.62e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SMAD3—allergic rhinitis	1.68e-05	5.61e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—ICAM1—allergic rhinitis	1.67e-05	5.59e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—TGFB1—allergic rhinitis	1.67e-05	5.59e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—NFKB1—allergic rhinitis	1.66e-05	5.56e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—NFKB1—allergic rhinitis	1.66e-05	5.56e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—TGFB1—allergic rhinitis	1.66e-05	5.55e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—TGFB1—allergic rhinitis	1.65e-05	5.53e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TAC1—allergic rhinitis	1.65e-05	5.53e-05	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—TGFB1—allergic rhinitis	1.65e-05	5.51e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—TGFB1—allergic rhinitis	1.64e-05	5.5e-05	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—TGFB1—allergic rhinitis	1.64e-05	5.48e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—ICAM1—allergic rhinitis	1.64e-05	5.48e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD4—allergic rhinitis	1.64e-05	5.47e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—ICAM1—allergic rhinitis	1.63e-05	5.45e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-DQB1—allergic rhinitis	1.63e-05	5.45e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD4—allergic rhinitis	1.63e-05	5.44e-05	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—TGFB1—allergic rhinitis	1.62e-05	5.42e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD4—allergic rhinitis	1.61e-05	5.4e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—ICAM1—allergic rhinitis	1.61e-05	5.39e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—NFKB1—allergic rhinitis	1.61e-05	5.37e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—ICAM1—allergic rhinitis	1.6e-05	5.36e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—SMAD3—allergic rhinitis	1.6e-05	5.36e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—TGFB1—allergic rhinitis	1.6e-05	5.35e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL5—allergic rhinitis	1.59e-05	5.33e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—NFKB1—allergic rhinitis	1.58e-05	5.3e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SMAD3—allergic rhinitis	1.58e-05	5.28e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—SMAD3—allergic rhinitis	1.54e-05	5.16e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.54e-05	5.16e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL5—allergic rhinitis	1.53e-05	5.14e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD4—allergic rhinitis	1.53e-05	5.12e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—NFKB1—allergic rhinitis	1.51e-05	5.06e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CD4—allergic rhinitis	1.5e-05	5.01e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—TGFB1—allergic rhinitis	1.47e-05	4.91e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—NFKB1—allergic rhinitis	1.46e-05	4.89e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TAC1—allergic rhinitis	1.46e-05	4.89e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—NFKB1—allergic rhinitis	1.46e-05	4.88e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—NFKB1—allergic rhinitis	1.45e-05	4.86e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD4—allergic rhinitis	1.44e-05	4.82e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD4—allergic rhinitis	1.44e-05	4.82e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TGFB1—allergic rhinitis	1.43e-05	4.78e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—TGFB1—allergic rhinitis	1.41e-05	4.72e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—NFKB1—allergic rhinitis	1.41e-05	4.72e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—NFKB1—allergic rhinitis	1.4e-05	4.69e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—ICAM1—allergic rhinitis	1.39e-05	4.66e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—NFKB1—allergic rhinitis	1.39e-05	4.65e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—TGFB1—allergic rhinitis	1.38e-05	4.64e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—TGFB1—allergic rhinitis	1.38e-05	4.64e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—TGFB1—allergic rhinitis	1.38e-05	4.62e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SMAD3—allergic rhinitis	1.38e-05	4.62e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—SMAD3—allergic rhinitis	1.37e-05	4.57e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL5—allergic rhinitis	1.36e-05	4.55e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—TGFB1—allergic rhinitis	1.35e-05	4.52e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SMAD3—allergic rhinitis	1.35e-05	4.51e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—NFKB1—allergic rhinitis	1.34e-05	4.5e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—ICAM1—allergic rhinitis	1.34e-05	4.49e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—TGFB1—allergic rhinitis	1.34e-05	4.48e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—NFKB1—allergic rhinitis	1.32e-05	4.41e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SMAD3—allergic rhinitis	1.32e-05	4.41e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SMAD3—allergic rhinitis	1.3e-05	4.34e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—NFKB1—allergic rhinitis	1.29e-05	4.32e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SMAD3—allergic rhinitis	1.29e-05	4.32e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD4—allergic rhinitis	1.26e-05	4.21e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—NFKB1—allergic rhinitis	1.24e-05	4.15e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—NFKB1—allergic rhinitis	1.24e-05	4.15e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD4—allergic rhinitis	1.23e-05	4.11e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TGFB1—allergic rhinitis	1.22e-05	4.08e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—TGFB1—allergic rhinitis	1.22e-05	4.07e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD4—allergic rhinitis	1.2e-05	4.03e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD4—allergic rhinitis	1.2e-05	4.01e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—TGFB1—allergic rhinitis	1.19e-05	4e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—ICAM1—allergic rhinitis	1.19e-05	3.97e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD4—allergic rhinitis	1.18e-05	3.96e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD4—allergic rhinitis	1.18e-05	3.94e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CD4—allergic rhinitis	1.16e-05	3.89e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—NFKB1—allergic rhinitis	1.16e-05	3.89e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—NFKB1—allergic rhinitis	1.14e-05	3.83e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CD4—allergic rhinitis	1.13e-05	3.8e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SMAD3—allergic rhinitis	1.12e-05	3.75e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TGFB1—allergic rhinitis	1.12e-05	3.75e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—NFKB1—allergic rhinitis	1.1e-05	3.69e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CD4—allergic rhinitis	1.09e-05	3.66e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CD4—allergic rhinitis	1.09e-05	3.64e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—NFKB1—allergic rhinitis	1.08e-05	3.63e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SMAD3—allergic rhinitis	1.08e-05	3.62e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—NFKB1—allergic rhinitis	1.06e-05	3.55e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—NFKB1—allergic rhinitis	1.06e-05	3.55e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—NFKB1—allergic rhinitis	1.06e-05	3.54e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—NFKB1—allergic rhinitis	1.04e-05	3.47e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—NFKB1—allergic rhinitis	1.03e-05	3.45e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—NFKB1—allergic rhinitis	1.02e-05	3.43e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD4—allergic rhinitis	1.02e-05	3.42e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—NFKB1—allergic rhinitis	1.02e-05	3.41e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—NFKB1—allergic rhinitis	1.01e-05	3.4e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—allergic rhinitis	9.86e-06	3.3e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFB1—allergic rhinitis	9.67e-06	3.24e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SMAD3—allergic rhinitis	9.56e-06	3.2e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFB1—allergic rhinitis	9.53e-06	3.19e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—allergic rhinitis	9.44e-06	3.16e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—allergic rhinitis	9.18e-06	3.07e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NFKB1—allergic rhinitis	9.11e-06	3.05e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—allergic rhinitis	9.1e-06	3.05e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NFKB1—allergic rhinitis	8.98e-06	3.01e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—allergic rhinitis	8.84e-06	2.96e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—allergic rhinitis	8.84e-06	2.96e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NFKB1—allergic rhinitis	8.81e-06	2.95e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—allergic rhinitis	8.73e-06	2.92e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—allergic rhinitis	8.52e-06	2.85e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NFKB1—allergic rhinitis	8.52e-06	2.85e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—NFKB1—allergic rhinitis	8.49e-06	2.84e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—allergic rhinitis	8.34e-06	2.79e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—allergic rhinitis	8.14e-06	2.72e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—allergic rhinitis	8.06e-06	2.7e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NFKB1—allergic rhinitis	8.02e-06	2.69e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—allergic rhinitis	7.84e-06	2.63e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—allergic rhinitis	7.8e-06	2.61e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—allergic rhinitis	7.59e-06	2.54e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—NFKB1—allergic rhinitis	7.52e-06	2.52e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—allergic rhinitis	7.48e-06	2.5e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—allergic rhinitis	7.1e-06	2.38e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NFKB1—allergic rhinitis	7.01e-06	2.35e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NFKB1—allergic rhinitis	6.84e-06	2.29e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—allergic rhinitis	6.78e-06	2.27e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NFKB1—allergic rhinitis	6.7e-06	2.24e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—allergic rhinitis	6.68e-06	2.24e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NFKB1—allergic rhinitis	6.59e-06	2.21e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NFKB1—allergic rhinitis	6.56e-06	2.2e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—allergic rhinitis	6.53e-06	2.19e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—allergic rhinitis	5.84e-06	1.95e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—allergic rhinitis	5.78e-06	1.94e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—allergic rhinitis	5.7e-06	1.91e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NFKB1—allergic rhinitis	5.7e-06	1.91e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—allergic rhinitis	5.58e-06	1.87e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—allergic rhinitis	5.49e-06	1.84e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NFKB1—allergic rhinitis	5.49e-06	1.84e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—allergic rhinitis	5.46e-06	1.83e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NFKB1—allergic rhinitis	4.86e-06	1.63e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—allergic rhinitis	4.75e-06	1.59e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—allergic rhinitis	4.57e-06	1.53e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—allergic rhinitis	4.05e-06	1.36e-05	CbGpPWpGaD
